SCHEMBL8203031

SCHEMBL8203031

CN(C(=O)c1c(O)cccc1O)c1ccc(C(=O)O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.47
CA1 P00915 3/20 0.47
CA2 P00918 3/20 0.47
CA7 P43166 3/20 0.47
CA9 Q16790 3/20 0.47
CA14 Q9ULX7 3/20 0.47
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
NPC1 O15118 2/20 0.44
POLB P06746 2/20 0.44
HSP90AA1 P07900 1/20 0.43
PDK2 Q15119 1/20 0.43
EGFR P00533 1/20 0.43
ERBB2 P04626 1/20 0.43
HTT P42858 1/20 0.43
KDM4E B2RXH2 1/20 0.42
THRB P10828 1/20 0.41
NR1H3 Q13133 2/20 0.40
NR1H2 P55055 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8204611 0.82 POLB (0.53) CA12CA1CA2CA7CA9
SCHEMBL9094961 0.80 KMT2A (0.56) KMT2AMEN1NPC1POLBHSP90AA1
SCHEMBL3089099 0.79 KMT2A (0.61) KMT2ANPC1EGFRERBB2HTT
SCHEMBL9567794 0.77 KMT2A (0.68) KMT2AMEN1NPC1POLBEGFR
SCHEMBL11041431 0.74 NPC1 (0.55) CA12CA1CA2CA7CA9
SCHEMBL5238532 0.73 ESR1 (0.54) KMT2AMEN1NPC1POLBHSP90AA1
SCHEMBL8201740 0.73 RXRA (0.56) NPC1HTTMAPTRAB9AHPGD
SCHEMBL24891812 0.72 EGFR (0.49) KMT2AMEN1NPC1POLBHSP90AA1
SCHEMBL8953838 0.72 POLB (0.53) CA12CA1CA2CA7CA9
SCHEMBL10457089 0.72 NPC1 (0.53) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6136969-A PROTEIN KINASE INHIBITORS; 4-HYDROXYBENZOIC ACID 3-(4-(4-FLUOROBENZOYLOXY)-BENZOYLAMINO)-AZEPAN-4-YL ESTER HOFFMANN-LA ROCHE INC. (US) 2000-10-24 US claimed
CN-1199396-A Novel azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases HOFFMANN LA ROCHE (CH) 1998-11-18 CN claimed
EP-0836592-A1 AZEPANES AND THEIR RING HOMOLOGUES FOR THERAPY AND PROPHYLAXIS OF PROTEIN KINASE MEDIATED DISEASES F. HOFFMANN-LA ROCHE AG (CH) 1998-04-22 EP claimed
WO-1997002249-A1 NOVEL AZEPANES AND THEIR RING HOMOLOGUES FOR THERAPY AND PROPHYLAXIS OF PROTEIN KINASE MEDIATED DISEASES F. HOFFMANN-LA ROCHE AG (CH) 1997-01-23 WO claimed
US-6136969-A PROTEIN KINASE INHIBITORS; 4-HYDROXYBENZOIC ACID 3-(4-(4-FLUOROBENZOYLOXY)-BENZOYLAMINO)-AZEPAN-4-YL ESTER HOFFMANN-LA ROCHE INC. (US) 2000-10-24 US disclosed
US-5907038-A PROTEIN KINASE INHIBITORS HOFFMANN-LA ROCHE INC. (US) 1999-05-25 US disclosed
CN-1199396-A Novel azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases HOFFMANN LA ROCHE (CH) 1998-11-18 CN disclosed
EP-0836592-A1 AZEPANES AND THEIR RING HOMOLOGUES FOR THERAPY AND PROPHYLAXIS OF PROTEIN KINASE MEDIATED DISEASES F. HOFFMANN-LA ROCHE AG (CH) 1998-04-22 EP disclosed
WO-1997002249-A1 NOVEL AZEPANES AND THEIR RING HOMOLOGUES FOR THERAPY AND PROPHYLAXIS OF PROTEIN KINASE MEDIATED DISEASES F. HOFFMANN-LA ROCHE AG (CH) 1997-01-23 WO disclosed